The present invention provides granules for animal feed which comprise a polypeptide having superoxide dismutase activity and a polypeptide having catalase activity and methods for obtaining such.

The present invention provides granules for animal feed which comprise a polypeptide having superoxide dismutase activity and a polypeptide having catalase activity and methods for obtaining such.

A natural hydrocolloid system can be used in, e.g., pet food compositions. Another aspect of the present disclosure is pet food compositions comprising such a natural hydrocolloid system, and preparation methods thereof. The hydrocolloid system can use blends of fruit fibers, such as citrus and apple fibers, and/or plant-based polysaccharides, such as psyllium, okra, chia, flaxseed, or seaweed; and can provide a gravy and even a jelly with functionalities comparable to the existing gravies. The blends can replace currently used hydrocolloids and can be used in new recipes with natural and clean labels.

A natural hydrocolloid system can be used in, e.g., pet food compositions. Another aspect of the present disclosure is pet food compositions comprising such a natural hydrocolloid system, and preparation methods thereof. The hydrocolloid system can use blends of fruit fibers, such as citrus and apple fibers, and/or plant-based polysaccharides, such as psyllium, okra, chia, flaxseed, or seaweed; and can provide a gravy and even a jelly with functionalities comparable to the existing gravies. The blends can replace currently used hydrocolloids and can be used in new recipes with natural and clean labels.

The invention is a method for the palatable delivery of nutrients in dry pet feed comprising the doping of feed components with such nutrients and a related pet feed.

The invention is a method for the palatable delivery of nutrients in dry pet feed comprising the doping of feed components with such nutrients and a related pet feed.

This invention relates to a process for obtaining concentrates of minerals chelated with amino acids or small peptides comprising soybean aminogram, wherein the reaction mixture is formed by diluting the source of natural amino acids from soybean which can undergo additivation of synthetic amino acids from soybean with water, at a ratio ranging from 1:4-7 in mass of amino acids per volume of water, with the physical reaction medium being transformed in emulsion through micro shear using a rotation from 2,500 to 5,000 rpm, and the stoichiometric balance being an excess of metal ions in relation to the ligand ions of soybean amino acids, in a molar ratio varying between 1: 1.2-1.8 between divalent metal ions and amino acids ions, respectively. The concentrates of minerals chelated with amino acids from soybean aminogram, having concentrations higher than those existing today, present industrial application as food supplements or in animal nutrition feed.

This invention relates to a process for obtaining concentrates of minerals chelated with amino acids or small peptides comprising soybean aminogram, wherein the reaction mixture is formed by diluting the source of natural amino acids from soybean which can undergo additivation of synthetic amino acids from soybean with water, at a ratio ranging from 1:4-7 in mass of amino acids per volume of water, with the physical reaction medium being transformed in emulsion through micro shear using a rotation from 2,500 to 5,000 rpm, and the stoichiometric balance being an excess of metal ions in relation to the ligand ions of soybean amino acids, in a molar ratio varying between 1: 1.2-1.8 between divalent metal ions and amino acids ions, respectively. The concentrates of minerals chelated with amino acids from soybean aminogram, having concentrations higher than those existing today, present industrial application as food supplements or in animal nutrition feed.

The present invention is directed to the use of at least one SGLT-2 inhibitor in a non-human mammal, preferably ruminant, preferably for drying-off of a non-human mammal, preferably ruminant, as well as corresponding methods, such as improving and/or facilitating the drying-off of a non-human mammal, preferably ruminant, comprising administering to such non-human mammal, preferably ruminant, at least one SGLT-2 inhibitor.

The present invention is directed to the use of at least one SGLT-2 inhibitor in a non-human mammal, preferably ruminant, preferably for drying-off of a non-human mammal, preferably ruminant, as well as corresponding methods, such as improving and/or facilitating the drying-off of a non-human mammal, preferably ruminant, comprising administering to such non-human mammal, preferably ruminant, at least one SGLT-2 inhibitor.